Philipp Brauer
Vice President at EQT Life Sciences
Munich, Bavaria
Overview
Work Experience
Vice President
2024 - Current
Board observer for: - Innovative Molecules - Ariceum Therapeutics - Hotspot Therapeutics - ATB Therapeutics
Associate
2022 - 2024
Analyst
2021 - 2022
Analyst at EQT Life Sciences (formerly LSP), part of the investment team focused on private companies and involved in all stages of the investment process.
LSP BioVentures is a venture capital fund focused on opportunities in the life science arena.
Analyst
2020 - 2021
Fellow at M Ventures, the strategic corporate VC of Merck. Supporting the team in all aspects of the fund pipeline including scouting, deal flow, due diligence, portfolio company support, and exits.
Year in Research
2013 - 2014
Research in structural biology group, conducting research on intraflagellar trans- port proteins. Performed a full crystallographic research project from inception to publication, working together with a variety of team members to accomplish this in only nine months.
Intern
2012 - 2012
Summer internship focused on BBSome proteins in intraflagellar transport. Performed molecular cloning, expression and purification. Worked as an independent member of a small team.
Intern
2009 - 2009
Two week internship in a small biotech company focused on small molecule drug development and target discovery, involving mass spectrometry, mammalian tissue culture and analysis of mouse organ protein composition.